Your browser doesn't support javascript.
loading
Stratified glucose-lowering response to vildagliptin and pioglitazone by obesity and hypertriglyceridemia in a randomized crossover trial.
Brandon, Rebecca; Jiang, Yannan; Yeu, Rui Qian; Tweedie-Cullen, Ry; Smallman, Kate; Doherty, Glenn; Macaskill-Smith, Kerry A; Doran, Rebekah J; Clark, Penny; Moffitt, Allan; Merry, Troy; Nehren, Norma; King, Frances; Hindmarsh, Jennie Harré; Leask, Megan Patricia; Merriman, Tony R; Orr-Walker, Brandon; Shepherd, Peter R; Paul, Ryan; Murphy, Rinki.
Afiliación
  • Brandon R; Department of Medicine, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand.
  • Jiang Y; Maurice Wilkins Centre for Molecular Biodiscovery, Auckland, New Zealand.
  • Yeu RQ; Department of Statistics, Faculty of Sciences, The University of Auckland, Auckland, New Zealand.
  • Tweedie-Cullen R; National Institute for Health Innovation, School of Population Health, The University of Auckland, Auckland, New Zealand.
  • Smallman K; Department of Medicine, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand.
  • Doherty G; Maurice Wilkins Centre for Molecular Biodiscovery, Auckland, New Zealand.
  • Macaskill-Smith KA; Department of Medicine, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand.
  • Doran RJ; Maurice Wilkins Centre for Molecular Biodiscovery, Auckland, New Zealand.
  • Clark P; Diabetes Foundation Aotearoa, Auckland, New Zealand.
  • Moffitt A; Tongan Health Society, Auckland, New Zealand.
  • Merry T; Ventures/Pinnacle Incorporated, Hamilton, New Zealand.
  • Nehren N; Ventures/Pinnacle Incorporated, Hamilton, New Zealand.
  • King F; Ventures/Pinnacle Incorporated, Hamilton, New Zealand.
  • Hindmarsh JH; Procare Primary Health Organisation, Auckland, New Zealand.
  • Leask MP; Maurice Wilkins Centre for Molecular Biodiscovery, Auckland, New Zealand.
  • Merriman TR; Discipline of Nutrition, University of Auckland, Auckland, New Zealand.
  • Orr-Walker B; Te Hiku Hauora, Northland District Health Board, Kaitaia, New Zealand.
  • Shepherd PR; Ngati Porou Hauora, Tairawhiti, New Zealand.
  • Paul R; Ngati Porou Hauora, Tairawhiti, New Zealand.
  • Murphy R; Maurice Wilkins Centre for Molecular Biodiscovery, Auckland, New Zealand.
Front Endocrinol (Lausanne) ; 13: 1091421, 2022.
Article en En | MEDLINE | ID: mdl-36699039
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hipertrigliceridemia / Tiazolidinedionas / Diabetes Mellitus Tipo 2 / Inhibidores de la Dipeptidil-Peptidasa IV Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Límite: Adult / Humans Idioma: En Revista: Front Endocrinol (Lausanne) Año: 2022 Tipo del documento: Article País de afiliación: Nueva Zelanda
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hipertrigliceridemia / Tiazolidinedionas / Diabetes Mellitus Tipo 2 / Inhibidores de la Dipeptidil-Peptidasa IV Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Límite: Adult / Humans Idioma: En Revista: Front Endocrinol (Lausanne) Año: 2022 Tipo del documento: Article País de afiliación: Nueva Zelanda